John Bridgewater, BA, MBBS, MRCP, PHD, discusses the potential impact of the phase 3 HARMONi-GI1 trial on treating advanced biliary tract cancer.
John Bridgewater, BA, MBBS, MRCP, PhD
Advertisement
Articles by John Bridgewater, BA, MBBS, MRCP, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Late-Breaking Phase 3 Data Headline ESMO 2026 Presidential Symposium I
2
Investigating Novel Immunotherapy Targets in Metastatic RCC
3
Vopimetostat Plus Daraxonrasib Yields 82% ORR in MTAP-Deleted PDAC
4
Personalized mRNA Vaccine Intismeran Plus Pembro Cuts Melanoma Recurrence
5